Lung cancer trials in Croatia

4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 2/3Taking people
  Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7

  Where

  Grad Zagreb, Rijeka

  Age

  18 years and over

  People

  626 worldwide

  Run by

  Mirati Therapeutics Inc.

  See details and how to joinNCT04613596 · EU 2023-508922-83-00
• Phase 3Taking people
  A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)

  Where

  Dubrovnik, Grad Zagreb, Osijek, Rijeka, Split

  Age

  18 years and over

  People

  630 worldwide

  Run by

  Mirati Therapeutics Inc.

  See details and how to joinNCT06875310 · EU 2024-515698-85-00
• Phase 3Taking people
  A Study to Test How Well ZL-1310 may Work Compared to Therapies Selected by the Investigator in Treating Patients with Relapsed Small Cell Lung Cancer

  Where

  Grad Zagreb

  Age

  18 years and over

  People

  263 worldwide

  Run by

  Zai Lab (US) LLC

  See details and how to join2025-522818-23-00 · EU 2025-522818-23-00
• No phaseTaking people
  Effect of Apneic Oxygenation of the Non-ventilated Lung During Lung Cancer Surgery.

  Where

  Osijek

  Age

  18 years and over

  People

  56

  Run by

  Osijek University Hospital

  See details and how to joinNCT07393490